AMPH

Amphastar Pharmaceuticals, Inc.

20.35

USD

AMPH Earnings Reports

Positive Surprise Ratio

AMPH beat 32 of 41 last estimates.

78%

Next Report

Date of Next Report

May 05, 2026

Estimate for Q1 26 (Revenue/ EPS)

$177.57M

$0.73

Implied change from Q4 25 (Revenue/ EPS)

-3.02%

Implied change from Q1 25 (Revenue/ EPS)

+4.13%

-1.35%

Amphastar Pharmaceuticals, Inc. earnings per share and revenue

On Feb 26, 2026, AMPH reported earnings of 0.73 USD per share (EPS) for Q4 25, missing the estimate of 0.94 USD, resulting in a -22.40% surprise. Revenue reached 183.10 million, compared to an expected 194.29 million, with a -5.76% difference. The market reacted with a -23.63% price change (close before vs. close after earnings).

Looking ahead to Q1 26, 5 analysts forecast an EPS of 0.73 USD, with revenue projected to reach 177.57 million USD, implying an increase of 0.00% EPS, and decrease of -3.02% in Revenue from the last quarter.

FAQ

What were Amphastar Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Amphastar Pharmaceuticals, Inc. reported EPS of $0.73, missing estimates by -22.4%, and revenue of $183.10M, -5.76% below expectations.

How did the market react to Amphastar Pharmaceuticals, Inc.'s Q4 2025 earnings?

The stock price moved down -23.63%, changed from $26.49 before the earnings release to $20.23 the day after.

When is Amphastar Pharmaceuticals, Inc. expected to report next?

The next earning report is scheduled for May 05, 2026.

What are the forecasts for Amphastar Pharmaceuticals, Inc.'s next earnings report?

Based on 5 analysts, Amphastar Pharmaceuticals, Inc. is expected to report EPS of $0.73 and revenue of $177.57M for Q1 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.